Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
J Autoimmun
; 140: 103125, 2023 Oct 14.
Article
in En
| MEDLINE
| ID: mdl-37844543
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Autoimmun
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2023
Document type:
Article
Country of publication:
United kingdom